Emerging COVID-19 data indicates a significant role of thrombosis in morbidity/mortality of patients with ARDS, with evidence of clotting system activation; expert advice on the value and safety of anticoagulation favours LMWH/NOAC therapy
Read below to complete the CPD questions
Staying ahead of the curve
COVID-19 and Thrombosis
What you will learn:
As the coronavirus pandemic progresses, the critically important role of blood clotting has been recognised in publications from clinicians and scientists worldwide.
This programme:
As the coronavirus pandemic progresses, the critically important role of blood clotting has been recognised in publications from clinicians and scientists worldwide.
This programme:
- Explains how the response to the infection can trigger a cytokine storm affecting coagulation in seriously ill patients
- Emphasises the serious implications of these changes on the prognosis of COVID-19 patients
- Reviews the need for thromboprophylaxis in patients during and after their hospital stay
Presenter
Dr Tony Dalby
Specialist Cardiologist
Life Fourways Hospital
Johannesburg, South Africa
STAY AHEAD OF THE CURVE
Submission of questions are now closed
This report was made possible by an unrestricted educational grant from Bayer. The content of the report is independent of the sponsor.
